Zhou B - Search Results

1

Single-cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer.

Guo W, Zhou B, Bie F, Huai Q, Xue X, Guo L, Tan F, Xue Q, Zhao L, Gao S. Guo W, et al. Among authors: zhou b. Clin Transl Med. 2023 Oct;13(10):e1453. doi: 10.1002/ctm2.1453. Clin Transl Med. 2023. PMID: 37846760 Free PMC article.

2

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.

Zhou B, Gao S. Zhou B, et al. Front Mol Biosci. 2021 Apr 22;8:648402. doi: 10.3389/fmolb.2021.648402. eCollection 2021. Front Mol Biosci. 2021. PMID: 33968987 Free PMC article.

3

Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma.

Zhou B, Gao S. Zhou B, et al. Cancer Immunol Immunother. 2022 May;71(5):1183-1197. doi: 10.1007/s00262-021-03066-4. Epub 2021 Oct 11. Cancer Immunol Immunother. 2022. PMID: 34635925 Free PMC article.

4

Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m⁶A Regulators in Early-Stage Lung Adenocarcinoma.

Zhou B, Gao S. Zhou B, et al. Front Immunol. 2021 Sep 28;12:698236. doi: 10.3389/fimmu.2021.698236. eCollection 2021. Front Immunol. 2021. PMID: 34650549 Free PMC article.

5

Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.

Bie F, Tian H, Sun N, Zang R, Zhang M, Song P, Liu L, Peng Y, Bai G, Zhou B, Gao S. Bie F, et al. Among authors: zhou b. Clin Epigenetics. 2021 Dec 21;13(1):229. doi: 10.1186/s13148-021-01221-3. Clin Epigenetics. 2021. PMID: 34933667 Free PMC article.

6

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC.

Bie F, Tian H, Sun N, Zang R, Zhang M, Song P, Liu L, Peng Y, Bai G, Zhou B, Gao S. Bie F, et al. Among authors: zhou b. Front Oncol. 2022 Feb 9;12:769124. doi: 10.3389/fonc.2022.769124. eCollection 2022. Front Oncol. 2022. PMID: 35223466 Free PMC article. Review.

7

Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study.

Zhou B, Zang R, Zhang M, Song P, Liu L, Bie F, Peng Y, Bai G, Gao S. Zhou B, et al. EBioMedicine. 2022 Apr;78:103951. doi: 10.1016/j.ebiom.2022.103951. Epub 2022 Mar 18. EBioMedicine. 2022. PMID: 35313216 Free PMC article.

8

Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.

Zhou B, Zang R, Zhang M, Song P, Liu L, Bie F, Peng Y, Bai G, Gao S. Zhou B, et al. Int Immunopharmacol. 2022 Aug;109:108816. doi: 10.1016/j.intimp.2022.108816. Epub 2022 Apr 30. Int Immunopharmacol. 2022. PMID: 35504200

9

Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC.

Zhang F, Guo W, Zhou B, Wang S, Li N, Qiu B, Lv F, Zhao L, Li J, Shao K, Xue Q, Gao S, He J. Zhang F, et al. Among authors: zhou b. J Thorac Oncol. 2022 Jul;17(7):909-920. doi: 10.1016/j.jtho.2022.04.012. Epub 2022 May 10. J Thorac Oncol. 2022. PMID: 35550174 Free article. Clinical Trial.

10

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma.

Peng Y, Qiu B, Tan F, Xu J, Bie F, He H, Liu L, Tian H, Bai G, Zhou B, Li Y, Huai Q, Yang Z, Gao S. Peng Y, et al. Among authors: zhou b. Thorac Cancer. 2022 Jul;13(14):2014-2023. doi: 10.1111/1759-7714.14478. Epub 2022 May 24. Thorac Cancer. 2022. PMID: 35611464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,755 results

Search Page

Filters